Evidence map›Paper›PMID 42286436›Full record

Trial reportAddiction (Abingdon, England)2026

A latent class analysis of clinical complexity: Secondary analysis of the collaboration leading to addiction treatment and recovery from other stresses (CLARO) randomized trial.

Megan S Schuler, Rebecca Weir, Colleen M McCullough, Grace M Hindmarch, Beth Ann Griffin, Kirsten Becker, Lisa S Meredith, Katherine E Watkins

Abstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Megan S SchulerRAND, Arlington, VA, USA.ORCID https://orcid.org/0000-0002-6009-8367
Rebecca WeirRAND, Arlington, VA, USA.ORCID https://orcid.org/0009-0006-8579-1594
Colleen M McCulloughRAND, Santa Monica, CA, USA.
Grace M HindmarchRAND, Santa Monica, CA, USA.
Beth Ann GriffinRAND, Arlington, VA, USA.ORCID https://orcid.org/0000-0002-2391-4601
Kirsten BeckerRAND, Santa Monica, CA, USA.
Lisa S MeredithRAND, Santa Monica, CA, USA.
Katherine E WatkinsRAND, Santa Monica, CA, USA.

Funding

Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness - Recruitment ExtensionUF1MH121954 · NIMH · RAND CORPORATION · PI KOMAROMY, MIRIAM, WATKINS, KATHERINE E · 2019 to 2024
$15.8M
NIMH NIH HHS U01MH121954NIMH NIH HHS UF1 MH121954
6 · The paper itself

Abstract

BACKGROUND AND

aimsIndividuals with opioid use disorder (OUD) frequently present with co-occurring mental health conditions such as depression and posttraumatic stress disorder (PTSD), along with other mental health substance use disorders, physical health conditions and social determinants that together comprise 'clinical complexity.' Collaborative care (CC), a primary care-based behavioral health integration model, aims to improve outcomes through coordinated, patient-centered treatment. This study examined heterogeneity in baseline clinical complexity among participants in the CLARO (Collaboration Leading to Addiction Treatment and Recovery from Other Stresses) trial and assessed whether the effects of CC versus enhanced usual care (EUC) differed across clinical complexity groups.

methodsSecondary analysis of CLARO, a pragmatic randomized clinical trial (n = 797) of CC versus EUC for adults with OUD and depression and/or PTSD, conducted in 18 low-resourced primary care clinics in New Mexico and California, USA. Latent class analysis of baseline data identified subgroups defined by mental health and substance use as the main characteristics along with physical health and social challenges. Six-month treatment effects were estimated using one-step models that jointly estimated latent class membership and class-specific outcomes, incorporating class × treatment interactions. Outcomes included depression symptom severity, PTSD symptom severity, and buprenorphine utilization and prescribing duration.

resultsThree subgroups were identified: (1) low complexity (43%), with relative clinical and social stability; (2) mental health complexity (34%), with high psychiatric symptoms but lower substance use and moderate social adversity; and (3) high dual complexity (23%). Compared with EUC, CC was associated with lower depression severity at follow-up for the low-complexity class, but not for other classes. CC and EUC did not differ statistically significantly with respect to PTSD outcomes in any class. Buprenorphine utilization and prescribing duration outcomes were similar across CC and EUC treatment arms.

conclusionsThe effects of collaborative care may vary according to patients' baseline clinical complexity. Collaborative care appears to be associated with more favorable depression outcomes than enhanced usual care among participants with lower clinical complexity but not among those with higher clinical complexity.

Indexed as

Depressive DisorderOpioid-Related DisordersStress Disorders, Post-TraumaticAdultBuprenorphineComorbidityFemaleHumansLatent Class AnalysisMaleMiddle AgedPatient-Centered CarePrimary Health CareTreatment Effect HeterogeneityBuprenorphineclinical complexitycollaborative caredepressionlatent class analysisopioid use disorderposttraumatic stress disorderprimary care

Identifiers

PMID42286436
PMCPMC13578843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.